When you use our sites, PAREXEL will assign cookie files (“Cookies”) to you, which are a small amount of information we send to your web browser. Cookies enable the computers operating our websites to differentiate between visitors and to track the patterns of activities engaged in by different visitors. By clicking the Continue Browsing button or continuing to use this site, you agree to accept the PAREXEL Privacy Policy and all Cookies deployed on this site. You may choose to continue browsing with cookies, or leave the site.

PAREXEL - Ubavka DeNoble Talks About PAREXEL's BioPharm Unit

The BioPharm unit is actually a business unit that is fully dedicated to collaboration with small to medium size companies. Our main objective is to execute and deliver clinical trial programs and pull compounds from early phase to late stage in development in the most efficient way.
Small and medium companies have different needs and we are in the situation to have appropriately tailored solutions for each of them. Our focus is on appropriate drug development plans that are supported by the expertise of the people that we have on board with operational excellence and operational optimization that will help us reach the same goal in a more cost efficient way.
We are a real partner for small and medium sized companies and the relationships we form with such companies are so strong, not only because we are able to overcome everything that is associated with the maintenance of the relationships, but because we are bringing expertise in drug development and we are bringing expertise in commercialization of the products that they would like to have in emerging and growing markets.
The BioPharm unit has had the opportunity to work with small companies around the world, but what we praise and what we learn in such a journey is to appreciate cultural differences and to help people penetrate markets that are emerging which are very important markets for small and medium sized companies.